Kala Subramanian
2016
In 2016, Kala Subramanian earned a total compensation of $1.7M as Senior Vice President, Strategic Development and Operations at CRISPR Therapeutics AG.
Compensation breakdown
Bonus | $150,000 |
---|---|
Non-Equity Incentive Plan | $67,238 |
Option Awards | $1,271,498 |
Salary | $180,386 |
Other | $2,045 |
Total | $1,671,167 |
Subramanian received $1.3M in option awards, accounting for 76% of the total pay in 2016.
Subramanian also received $150K in bonus, $67.2K in non-equity incentive plan, $180.4K in salary and $2K in other compensation.
Rankings
In 2016, Kala Subramanian's compensation ranked 5,735th out of 14,075 executives tracked by ExecPay. In other words, Subramanian earned more than 59.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,735 out of 14,075 | 59th |
Division Manufacturing | 2,080 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 671 out of 1,895 | 65th |
Industry group Drugs | 502 out of 1,538 | 67th |
Industry Biological Products, Except Diagnostic Substances | 87 out of 279 | 69th |
Source: SEC filing on April 18, 2017.
Subramanian's colleagues
We found three more compensation records of executives who worked with Kala Subramanian at CRISPR Therapeutics AG in 2016.